<DOC>
	<DOC>NCT00170768</DOC>
	<brief_summary>The purpose of this study is to explore the possible cognitive effects of darifenacin modified release and long-acting oxybutynin.</brief_summary>
	<brief_title>Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and Over</brief_title>
	<detailed_description />
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Males and females aged 60 and over United States English as a primary language Given written informed consent by signing and dating an informed consent form prior to study entry Current diseases in which the use of anticholinergic drugs is contraindicated, including the use of drugs with anticholinergic effects Volunteers with history of urinary retention or current bladder outlet obstruction, as determined by the investigator Other protocol defined inclusion/exclusion criteria may apply. Current use of drugs known to effect memory and cognition Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Darifenacin, oxybutynin, cognition, memory</keyword>
</DOC>